UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Positive impact of molecular analysis on prognostic scores in essential thrombocythemia: a single center prospective cohort experience

Haematologica (Roma), 2019-04, Vol.104 (4), p.e134

2019

Volltextzugriff (PDF)

Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm

Nature communications, 2022-09, Vol.13 (1), p.5346-5346, Article 5346

2022

Volltextzugriff (PDF)

Efficacy and tolerability of Janus kinase inhibitors in myelofibrosis: a systematic review and network meta-analysis

Blood cancer journal (New York), 2021-07, Vol.11 (7), p.135-135, Article 135

2021

Volltextzugriff (PDF)

Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis

American journal of hematology, 2024-08, Vol.99 (8), p.1644-1646

2024

Volltextzugriff (PDF)

Targeted molecular characterization shows differences between primary and secondary myelofibrosis

Genes chromosomes & cancer, 2020-01, Vol.59 (1), p.30-39

2020

Volltextzugriff (PDF)

Efficacy and safety of antibiotics targeting Gram-negative bacteria in nosocomial pneumonia: a systematic review and Bayesian network meta-analysis

Annals of intensive care, 2024-04, Vol.14 (1), p.66-66, Article 66

2024

Volltextzugriff (PDF)

Genetic basis and molecular profiling in myeloproliferative neoplasms

Blood, 2023-04, Vol.141 (16), p.1909-1921

2023

Volltextzugriff (PDF)

Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosis

Annals of hematology, 2022-04, Vol.101 (4), p.893-896

2022

Volltextzugriff (PDF)

Donor cell‐derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation

European journal of haematology, 2018-10, Vol.101 (4), p.570-574

2018

Volltextzugriff (PDF)

Absence of CALR mutations in JAK2-negative polycythemia

Haematologica (Roma), 2017-01, Vol.102 (1), p.e15

2017

Volltextzugriff (PDF)

Impact of Clonal Architecture on Clinical Course and Prognosis in Patients With Myeloproliferative Neoplasms

HemaSphere, 2023-05, Vol.7 (5), p.e885-n/a

2023

Volltextzugriff (PDF)

Deep learning shows no morphological abnormalities in neutrophils in Alzheimer's disease

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2021, Vol.13 (1), p.e12146-n/a

2021

Volltextzugriff (PDF)

JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes

Blood cancer journal (New York), 2022-04, Vol.12 (4), p.56-56, Article 56

2022

Volltextzugriff (PDF)

Myeloproliferative Neoplasms: The Long Wait for JAK2-Mutant Clone Expansion

Cell stem cell, 2021-03, Vol.28 (3), p.359-361

2021

Volltextzugriff (PDF)

Targeted High‐throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France

HemaSphere, 2023-09, Vol.7 (9), p.e943-n/a

2023

Volltextzugriff (PDF)

Improvement of Standardization of Molecular Analyses in Hematology: The 10‐year GBMHM French Experience

HemaSphere, 2021-12, Vol.5 (12), p.e658-n/a

2021

Volltextzugriff (PDF)

Blood smear invaders: About a fatal case of bacteremia

International journal of laboratory hematology, 2024-08, Vol.46 (4), p.593-594

2024

Volltextzugriff (PDF)

JAK2-V617F and interferon-α induce megakaryocyte-biased stem cells characterized by decreased long-term functionality

Blood, 2021-04, Vol.137 (16), p.2139-2151

2021

Volltextzugriff (PDF)

Detection of intrinsic pathway factor deficiency associated with bleeding risk by kaolin‐based aPTT

International Journal of Laboratory Hematology, 2020-06, Vol.42 (3), p.e107-e109

2020

Volltextzugriff (PDF)

Imatinib Treatment of Chronic Myeloid Leukemia Reveals a Preexisting CALR‐mutated Essential Thrombocythemia

HemaSphere, 2018-01, Vol.2 (1), p.e29-n/a

2018

Volltextzugriff (PDF)

No detection of atypical one-base deletion of CALR exon 9 with fragment analysis: A molecular trap to avoid

Blood cells, molecules, & diseases, 2021-09, Vol.90, p.102589, Article 102589

2021

Volltextzugriff (PDF)

Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scores

American journal of hematology, 2023-06, Vol.98 (6), p.922-931

2023

Volltextzugriff (PDF)

Next generation sequencing redefines a triple negative essential thrombocythaemia as double‐positive with rare mutations on JAK2 V617 and MPL W515 hotspots

British journal of haematology, 2019-09, Vol.186 (5), p.785-788

2019

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(43)
Hematology
(37)
Life Sciences
(35)
Humans
(27)
Mutation
(20)
Cancer
(18)
Janus Kinase 2 - Genetics
(14)
Female
(13)
Oncology
(13)
Middle Aged
(12)
Male
(11)
Calreticulin - Genetics
(10)
Myeloproliferative Disorders - Genetics
(10)
Human Health And Pathology
(9)
Prognosis
(9)
Adult
(7)
Aged
(7)
Leukemia
(7)
Thrombocythemia, Essential - Genetics
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Positive impact of molecular analysis on prognostic scores in essential thrombocythemia: a single center prospective cohort experience

Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm

Efficacy and tolerability of Janus kinase inhibitors in myelofibrosis: a systematic review and network meta-analysis

Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis

Targeted molecular characterization shows differences between primary and secondary myelofibrosis

Efficacy and safety of antibiotics targeting Gram-negative bacteria in nosocomial pneumonia: a systematic review and Bayesian network meta-analysis

Genetic basis and molecular profiling in myeloproliferative neoplasms

Sequential mutational evaluation of CALR ‐mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression

Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosis

Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation

Donor cell‐derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation

Absence of CALR mutations in JAK2-negative polycythemia

Impact of Clonal Architecture on Clinical Course and Prognosis in Patients With Myeloproliferative Neoplasms

Deep learning shows no morphological abnormalities in neutrophils in Alzheimer's disease

JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes

Myeloproliferative Neoplasms: The Long Wait for JAK2-Mutant Clone Expansion

Targeted High‐throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France

Improvement of Standardization of Molecular Analyses in Hematology: The 10‐year GBMHM French Experience

Blood smear invaders: About a fatal case of bacteremia

JAK2-V617F and interferon-α induce megakaryocyte-biased stem cells characterized by decreased long-term functionality

Detection of intrinsic pathway factor deficiency associated with bleeding risk by kaolin‐based aPTT

Imatinib Treatment of Chronic Myeloid Leukemia Reveals a Preexisting CALR‐mutated Essential Thrombocythemia

No detection of atypical one-base deletion of CALR exon 9 with fragment analysis: A molecular trap to avoid

Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scores

Next generation sequencing redefines a triple negative essential thrombocythaemia as double‐positive with rare mutations on JAK2 V617 and MPL W515 hotspots

Suchergebnisse filtern